What LEXICON PHARMACEUTICALS, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 9 |
| Sells | 0 | 0 |
| Total trades | 1 | 46 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 30,064 | 47,329,034 |
| Disposed | 0 | 676,672 |
| Net activity | +30,064 | +46,652,362 |
Common stock only — 2 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Exton Michael | Chief Executive Officer | Nov 06 | Open-market buy · P | +30,064 | $1.66 | +$50K | 328,496 |
| Barker Sam L | Director | Jun 03 | Exercise / conversion · M | +89,312 | — | — | 213,771 |
| Cheung Ivan | Director | Jun 03 | Exercise / conversion · M | +89,312 | — | — | 89,312 |
| Swain Judith L | Director | Jun 03 | Exercise / conversion · M | +89,312 | — | — | 174,486 |
| Amouyal Philippe | Director | Jun 03 | Exercise / conversion · M | +89,312 | — | — | 374,486 |
| Sobecki Christopher J | Director | Jun 03 | Exercise / conversion · M | +89,312 | — | — | 293,177 |
| Sullivan Diane E. | Director | Jun 03 | Exercise / conversion · M | +89,312 | — | — | 126,122 |
| Debbane Raymond | Director | Jun 03 | Exercise / conversion · M | +89,312 | — | — | 1,995,498 |
| Artal Participations S.a r.l. | Director | Apr 30 | Exercise / conversion · M | +20,421,735 | — | — | 175,156,062 |
| Crum Brian T | SVP, General Counsel & Secr. | Feb 28 | Withheld — tax / exercise cost · F | −105,019 | $1.47 | −$154K | 428,802 |
| Crum Brian T | SVP, General Counsel & Secr. | Feb 28 | Exercise / conversion · M | +170,163 | — | — | 533,821 |
| Crum Brian T | SVP, General Counsel & Secr. | Feb 28 | Exercise / conversion · M | +69,386 | — | — | 330,201 |
| Gopinathan Suma | SVP, Discovery | Feb 28 | Withheld — tax / exercise cost · F | −24,338 | $1.47 | −$35.8K | 150,132 |
| Gopinathan Suma | SVP, Discovery | Feb 28 | Exercise / conversion · M | +65,640 | — | — | 174,470 |
| Martens Rachel Yap | SVP, Partnerships & Corp Strat | Feb 28 | Withheld — tax / exercise cost · F | −35,826 | $1.47 | −$52.7K | 31,264 |
| Gopinathan Suma | SVP, Discovery | Feb 28 | Exercise / conversion · M | +20,310 | — | — | 108,830 |
| Gopinathan Suma | SVP, Discovery | Feb 28 | Exercise / conversion · M | +14,000 | — | — | 88,520 |
| McDermott Wendy | SVP, Human Resources | Feb 28 | Withheld — tax / exercise cost · F | −68,107 | $1.47 | −$100K | 277,945 |
| McDermott Wendy | SVP, Human Resources | Feb 28 | Exercise / conversion · M | +144,393 | — | — | 346,052 |
| McDermott Wendy | SVP, Human Resources | Feb 28 | Exercise / conversion · M | +52,316 | — | — | 201,659 |
Loading...